Insider Transactions in Q4 2020 at Alpine Immune Sciences, Inc. (ALPN)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2020
|
James Paul Rickey Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,258
-8.59%
|
$27,096
$12.6 P/Share
|
|
Dec 31
2020
|
Mitchell Gold Executive Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,123
-3.46%
|
$133,476
$12.6 P/Share
|
|
Dec 31
2020
|
Stanford L Peng Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,923
-13.87%
|
$47,076
$12.6 P/Share
|
|
Dec 28
2020
|
Peter A. Thompson Director |
SELL
Open market or private sale
|
Indirect |
600,000
-16.34%
|
$8,400,000
$14.25 P/Share
|
|
Dec 28
2020
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
600,000
-16.34%
|
$8,400,000
$14.25 P/Share
|
|
Dec 22
2020
|
Jay Venkatesan Director |
BUY
Other acquisition or disposition
|
Direct |
181,024
+47.17%
|
-
|
|
Dec 22
2020
|
Jay Venkatesan Director |
SELL
Other acquisition or disposition
|
Indirect |
993,801
-24.88%
|
-
|
|
Dec 22
2020
|
Alpine Immuno Sciences, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
993,801
-24.88%
|
-
|
|
Dec 22
2020
|
Mitchell Gold Executive Chairman and CEO |
BUY
Other acquisition or disposition
|
Direct |
260,528
+44.79%
|
-
|
|
Dec 22
2020
|
Mitchell Gold Executive Chairman and CEO |
SELL
Other acquisition or disposition
|
Indirect |
993,801
-24.88%
|
-
|
|
Nov 19
2020
|
Robert E Conway Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+28.57%
|
$80,000
$8.03 P/Share
|